1. Home
  2. MG vs DNA Comparison

MG vs DNA Comparison

Compare MG & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mistras Group Inc

MG

Mistras Group Inc

HOLD

Current Price

$21.67

Market Cap

531.0M

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$10.48

Market Cap

458.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MG
DNA
Founded
1978
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
531.0M
458.6M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
MG
DNA
Price
$21.67
$10.48
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
★ $8.50
AVG Volume (30 Days)
423.8K
★ 1.4M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 46.49
EPS
★ 0.30
N/A
Revenue
★ $700,970,000.00
$170,155,000.00
Revenue This Year
$5.47
N/A
Revenue Next Year
$3.59
N/A
P/E Ratio
$71.27
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$9.37
$5.37
52 Week High
$21.57
$17.58

Technical Indicators

Market Signals
Indicator
MG
DNA
Relative Strength Index (RSI) 70.44 72.44
Support Level $13.75 $6.69
Resistance Level N/A $10.76
Average True Range (ATR) 0.57 0.71
MACD 0.11 0.40
Stochastic Oscillator 92.31 95.47

Price Performance

Historical Comparison
MG
DNA

About MG Mistras Group Inc

MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International, and Products and Systems, of which key revenue is derived from the North America segment. The North America segment provides asset protection solutions, including NDT, inspection, and mechanical and engineering services, along with software, digital, and data services.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: